Trifluoromethyl substituted benzamides as kinase inhibitors

Details for Australian Patent Application No. 2005270313 (hide)

Owner Novartis AG

Inventors Imbach, Patricia; Perez, Lawrence Blas; Caravatti, Giorgio; Sheng, Tao; Martiny-Baron, Georg; Furet, Pascal

Agent Davies Collison Cave

Pub. Number AU-A-2005270313

PCT Pub. Number WO2006/015859

Priority 0417905.7 11.08.04 GB

Filing date 10 August 2005

Wipo publication date 16 February 2006

International Classifications

C07D 217/02 (2006.01) Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems

C07D 237/30 (2006.01) Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings

C07D 239/74 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

C07D 239/84 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

C07D 277/62 (2006.01) Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings

Event Publications

1 March 2007 PCT application entered the National Phase

  PCT publication WO2006/015859 Priority application(s): WO2006/015859

22 April 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005270314-Pyrazole derivatives for treating conditions mediated by activation of the adenosine A2b or A3 receptor

2005270308-Azetidine derivatives as CCR-3 receptor antagonists